Surgery Following Induction (Neoadjuvant) Therapy with Pembrolizumab in Lung Adenocarcinoma with High PD-L1 Expression. Respirar [Internet]. 2025 Oct. 10 [cited 2026 Aug. 25];17(1):68-75. Available from: https://respirar.alatorax.org/index.php/respirar/article/view/268